Cromwell Holdings’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Cromwell Holdings's RPRX Position: Q3 2026 in Review
Cromwell Holdings held its Royalty Pharma (RPRX) position steady in Q3 2026 at 135 shares worth $7.88K. The position accounts for ﹤0.01% of the portfolio, ranked #638.
Cromwell Holdings first reported a position in RPRX in Q1 2025 and has held it in 7 quarters since. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Cromwell Holdings held 135 shares of Royalty Pharma worth $7.88K as of Q3 2026.
- Cromwell Holdings left its Royalty Pharma share count unchanged in Q3 2026.
- Royalty Pharma made up ﹤0.01% of Cromwell Holdings's portfolio in Q3 2026, its #638 holding.
- Cromwell Holdings first reported a position in Royalty Pharma in Q1 2025 and has held it in 7 quarters since.
- 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Cromwell Holdings's 13F filing for Q3 2026, filed 28 Oct 2026.